BeStock  
Markets › Compare › RPRX vs WRB

RPRX vs WRB

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
RPRX · Royalty Pharma$57.39 ▼ 1.66%
WRB · WR Berkley$68.83 ▲ 1.91%

Head to head

MetricRPRXWRB
Price$57.39$68.83
Change today▼ 1.66%▲ 1.91%
Market cap$25.55B$25.55B
Return, 3 months–-2.4%
Return, year to date–-0.7%
Return, 1 year–-6.2%
P/E (TTM)30.914.2
P/B3.72.6
P/E percentile vs own 5y67th18th
Dividend yield1.59%0.54%
Revenue growth (YoY, latest qtr)+16.5%+2.7%
Net profit growth (YoY)-12.0%+12.9%
Gross margin––
Operating margin62.3%–
Net margin32.0%12.9%
Return on equity12.3%20.2%
Analyst target vs. price+14.5%+5.5%
Analyst buy share100%20%
RSI (14)–41
30-day volatility–15.7%
Max drawdown, 1 year–-17.6%
Trend read–Leaning bearish
Analyst consensusBuyHold

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • RPRX is the largest of the group by market value.
  • WRB carries the lowest trailing P/E.
  • RPRX pays the highest dividend yield.
  • RPRX is growing revenue fastest.
  • RPRX keeps the most profit per dollar of sales.

Go deeper

Scroll to Top